Ischemic heart disease is the most common cause of death in the world. It begins with a heart attack, also known as a myocardial infarction (MI), which causes part of the heart to die due to ...

In this article we summarize the experimental studies providing novel concepts for cell-enhancement strategies to aid the treatment of peripheral artery occlusive and ischemic heart disease.

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...

Dr Matthew Molloy, GPSI in cardiology, explains the latest knowledge and best practice in the management of Ischaemic Heart ...

People with heart disease — and more specifically, heart failure — are extremely vulnerable to air pollution-induced ...

Approval announced for injection medication aimed at treatment for adults for obesity and risk of non-fatal myocardial ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...